Key result
Native septal puncture enables successful AF cryoablation after failed transseptal access across an Occlutech device.
Why the study?
Patients with atrial septal defects remain at high risk of developing atrial fibrillation even after defect closure.
Case Report (n=1)
No
Direct transseptal puncture across an Occlutech Figulla Flex II atrial septal defect closure device carries a risk of needle penetration failure and sheath entrapment due to its dense right atrial disc nitinol mesh, making imaging-guided puncture of the native septum preferable.
Answers are grounded in this paper and cite their sources.
Direct puncture through Occlutech ASD occluder risks sheath entrapment; leaves open optimal transseptal access for AF ablation post-closure.
Pulmonary vein (PV) isolation, which involves electrical isolation of PV foci using cryoballoon ablation, is a useful treatment strategy for atrial fibrillation (AF) worldwide1. Patients with atrial septal defects (ASDs) are at high risk of developing AF, which remains considerable even after ASD closure2.
No takes yet. Share an insight, caveat, or question.
Nyuta et al. (2025) conducted a case report in Drug-refractory paroxysmal atrial fibrillation with a previously implanted Occlutech atrial septal defect closure device (n=1). Direct transseptal puncture across the Occlutech atrial septal defect closure device followed by transseptal puncture through the native anteroinferior septum and cryoballoon pulmonary vein isolation was evaluated on Procedural feasibility of transseptal puncture and freedom from atrial fibrillation recurrence. Direct transseptal puncture across an Occlutech ASD closure device failed and entrapped the sheath, whereas native septal puncture enabled successful cryoballoon ablation with 10-month AF freedom.
Synapse has enriched 10 related papers. Consider them for comparative context: